Other newly identified targets of miR‐21, including Maspin, MARCKS, and RECK, have been shown to participate in decreasing cancer cell invasion through matrigel and therefore warrant exploration into their ability to do so in melanoma [19, 27, 40, 41]. The gene discussed is MARCKS; the disease is melanoma.